Research Collaborators

Rebecca Cunningham, PhD

Member, Institute for Health Aging
Professor, Pharmaceutical Sciences
Associate Dean for Research, UTN System College of Pharmacy

HSC Expert Profile

The Cunningham lab is focused on the neurobiology of steroid hormones, neuropeptides, and oxidative stress mediated mechanisms in order to examine sex differences in neurodegenerative diseases (e.g., Alzheimer’s disease). We are one of the first laboratories to examine how oxidative stress alters the functional outcomes of steroid hormones, such as androgens and estrogens.

Kyle Emmitte, PhD

Chair and Professor, Pharmaceutical Sciences
UTN System College of Pharmacy

HSC Expert Profile
Publish work

My medicinal chemistry laboratory is engaged in the design, synthesis, and optimization of small molecules to serve as chemical probes, drug leads, and preclinical candidates. We have experience using a variety of strategies for hit discovery and optimization, including high-throughput screening, parallel library synthesis, computer-aided drug design, and de novo design approaches. We utilize traditional synthetic organic chemistry as well as specialized technology such as microwave-assisted organic synthesis and flow chemistry to prepare synthetic intermediates and new chemical entities. We have experience developing structure-activity relationships to drive programs forward around a host of properties, including potency, selectivity, permeability, metabolism, protein binding, clearance, and bioavailability. Our work is highly collaborative and conducted in partnership with colleagues who have expertise in computational chemistry, biology, pharmacology, and drug metabolism and pharmacokinetics.

Eul Suh, PhD

Assistant Professor, Pharmaceutical Sciences
UTN System College of Pharmacy

HSC Expert Profile

My laboratory focuses on developing novel molecular imaging probes to elucidate and visualize metabolic abnormalities associated with diseases. In collaboration with Dr. Inman’s research group, we are using ¹⁸F-FDG PET/MRI to gain a deeper understanding of the metabolic changes involved in glaucoma. By visualizing metabolic activity in real time, we aim to uncover the underlying mechanisms driving the disease. This approach could provide valuable insights into glaucoma’s progression and potentially identify new therapeutic targets.